I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Oxaliplatin is an anti-tumor agent with activity against colorectal cancer. It shows antitumor activity in cell lines with acquired cisplatin resistance. It is used to treat cancer of the gullet (oesophagus). It is used as adjuvant therapy in patients who have had surgery to remove the cancer. It is used to treat testicular cancer.
D Khayat; M Gil-Delgado; E C Antoine; D Nizri; G Bastian. The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer. Oncology (Williston Park, N.Y.).2001, 15, (4), 414-415.
Peter Draxler; Silke Doris Honsek; Liesbeth Forsthuber; Viktoria Hadschieff; Jürgen Sandkühler. VGluT3? primary afferents play distinct roles in mechanical and cold hypersensitivity depending on pain etiology. Journal of Neuroscience.2014, 34, (36), 12015-12028.
Gefahrenhinweise (EU): H315-H319-H334-H317-H335
Causes skin irritation. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction. May cause respiratory irritation.
Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Wear protective gloves. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.